Tetraphase Pharmaceuticals Stock Price (NASDAQ:TTPH)

Add to My Stocks
$3.01 $0.11 (3.79%) TTPH stock closing price Sep 19, 2018 (Closing)
Prev Close* : $2.9
Market Cap:
$153.29M
Day Low: $2.88
52 Week Low: $2.05
Open: $2.9
Volume: -
Day High: $3.05
52 Week High: $7.98
Dividend:
0.00

Latest Stock Market News

Latest Articles

Tetraphase Pharmaceuticals News - From Partners

TTPH Stockcharts

View TTPH PE ratio, PS ratio stocks charts and compare with peers.
TTPH Chart
Note: Compare Tetraphase Pharmaceuticals stock price history with the index and industry peers.

Tetraphase Pharmaceuticals Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
7.77
PB ratio (
price to book ratio
)
1.28

Tetraphase Pharmaceuticals Returns

ROE
(return on equity)
-69%

Tetraphase Pharmaceuticals Financial Ratios

Asset Turnover
0.37
Receivables Turnover
5.83
Debt to Equity
0
Dividend Yield
0%

TTPH Industry Peers

Company Price Change (%)
Redhill Biopharma (RDHL)80 (0%)
Avadel Pharma (AVDL)4.40.11 (2.56%)
Nature's Sunshine Products (NATR)9.10.1 (1.11%)
Aldeyra Therapeutics (ALDX)8.050.2 (2.55%)
Cormedix (CRMD)0.610 (0%)
Otonomy (OTIC)2.60 (0%)
Insmed (INSM)20.310.86 (4.42%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Tetraphase Pharmaceuticals Inc Stock News - Partner Headlines

Tetraphase Pharmaceuticals Financial Statements

income statement20172016201520142013
Net Sales or Revenues9.66M5.14M11.68M9.09M10.48M
Net Income-114.75M-77.48M-83.18M-66.74M-29.63M
Total Operating Expense125.37M82.97M94.67M74.86M38.66M
View Tetraphase Pharmaceuticals income statement
balance sheet20172016201520142013
Total Assets149.04M151.71M214.91M127.2M105.88M
Total Liabilities18.63M11.65M10.86M18.63M18.07M
Shareholders Equity130.41M140.05M204.05M108.56M87.8M
View Tetraphase Pharmaceuticals balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities4.3M--5.46M3.42M3.42M
Net Cash from (used by) Operating Activities-98.05M-63.76M-76.7M-57.62M-24.5M
Increase (Decrease) in Prop Plant And Equipment-0.77M-0.39M-0.83M-0.19M-0.12M
View Tetraphase Pharmaceuticals cash flow statement

Tetraphase Pharmaceuticals Stock Message Board

As of last trading day, Tetraphase Pharmaceuticals stock price was $3.01. Tetraphase Pharmaceuticals market capitalization is $153.29M and it represents the total market value of TTPH stock. Tetraphase Pharmaceuticals valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy TTPH stock than sell it, then Tetraphase Pharmaceuticals stock price goes up. Conversely, if more investors wanted to sell TTPH stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Tetraphase Pharmaceuticals stock quote data shows the number of shares traded. For Ex: 789,719 Tetraphase Pharmaceuticals shares were traded as of last trading day, as seen from Tetraphase Pharmaceuticals stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Tetraphase Pharmaceuticals does not pay dividends. Tetraphase Pharmaceuticals stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.